Kohjin Bio Co., Ltd.
コージンバイオ株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 177A
FY2025 (Mar 2026) · J-GAAP · consolidated Source: filing S100YB5D
FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2025 (Mar 2026) runs Apr 1, 2025 – Mar 31, 2026.
| Gross margin | 37.6% |
|---|---|
| Operating margin | 6.9% |
| Net margin | 5.1% |
| Return on equity | 4.3%Includes one-off items (e.g. gains on negative goodwill) |
| Return on assets | 2.8% |
| Revenue growth (YoY) | -5.1% |
| EPS (basic) | ¥49.11 |
| EPS growth (YoY) | -68.8% |
| Current ratio | 1.80x |
| Equity ratio | 66.8% |
| Book value / share | ¥1,163.08 |
| Free cash flow | −¥272M |